Pluri (PLUR) Non Operating Income (2012 - 2025)
Pluri (PLUR) reported Non Operating Income of -$143000.0 for Q4 2025, down 106.95% year-over-year from $2.1 million in Q4 2024, and down 168.1% quarter-over-quarter from $210000.0 in Q3 2025.
Pluri (PLUR) Non Operating Income (2012 - 2025) Analysis & Trends
Pluri (PLUR) has 13 years of Non Operating Income data on file, last reported at -$143000.0 in Q4 2025.
- Non Operating Income for Q4 2025 came in at -$143000.0, down 106.95% year-over-year; the trailing twelve-month figure through Dec 2025 was -$1.1 million (down 143.82% YoY), and the FY2025 annual result was -$206000.0, down 112.26% from the prior year.
- Non Operating Income declined to -$143000.0 in Q4 2025 per PLUR's latest filing, from $210000.0 in the prior quarter.
- Over five years, Non Operating Income peaked at $2.1 million in Q4 2024 and troughed at -$1.6 million in Q4 2022.
- A 4-year average of $99142.9 and a median of $244500.0 in 2023 frame the typical range for Non Operating Income.
- On a YoY basis, Non Operating Income climbed as much as 373.1% in 2024 and fell as far as 400.36% in 2024.
- A 4-year view of Non Operating Income shows it stood at -$1.6 million in 2022, then surged by 127.62% to $435000.0 in 2023, then jumped by 373.1% to $2.1 million in 2024, then slumped by 106.95% to -$143000.0 in 2025.
- Business Quant data shows PLUR's Non Operating Income at -$143000.0 in Q4 2025, $210000.0 in Q3 2025, and -$280000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | 5.75 Mn |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | 444,000.00 |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | - |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | 9.35 Mn |
| 10 | Pluri | 21.39 Mn | 21.87 Mn | 86,000.00 | -143,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -143,000.00 |
| Sep 30, 2025 | 210,000.00 |
| Jun 30, 2025 | -280,000.00 |
| Mar 31, 2025 | -935,000.00 |
| Dec 31, 2024 | 2.06 Mn |
| Sep 30, 2024 | -838,000.00 |
| Jun 30, 2024 | 1.04 Mn |
| Mar 31, 2024 | 362,000.00 |
| Dec 31, 2023 | 435,000.00 |
| Sep 30, 2023 | 279,000.00 |
| Jun 30, 2023 | 781,000.00 |
| Mar 31, 2023 | -658,000.00 |
| Dec 31, 2022 | -1.58 Mn |
| Sep 30, 2022 | 654,000.00 |
| Jun 30, 2020 | 378,000.00 |
| Mar 31, 2020 | -108,000.00 |
| Dec 31, 2019 | -2,000.00 |
| Sep 30, 2019 | 56,000.00 |
| Jun 30, 2019 | 171,000.00 |
| Mar 31, 2019 | 222,000.00 |